Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 5,031 $ 4,030
Cost of revenue 1,785 1,416
Gross profit 3,246 2,614
Research and development costs 2,533 1,563
Sales and marketing expenses 1,845 1,575
General and administrative expenses 2,732 1,657
Operating loss (3,864) (2,181)
Other expense:    
Other income (expense), net 11 (25)
Interest expense, net (106) (332)
Net loss $ (3,959) $ (2,538)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (0.17) $ (0.13)
Diluted (in dollars per share) $ (0.17) $ (0.13)
Weighted average shares used in computing net loss per share:    
Basic (in shares) 23,682,442 18,852,828
Diluted (in shares) 23,682,442 18,852,828
Product revenue    
Revenue:    
Total revenue $ 3,163 $ 3,162
Service and other revenue    
Revenue:    
Total revenue $ 1,868 $ 868